Journal Club - Meningitis vaccine to tackle drug resistance in Neisseria gonorrhoeae Isra Zaman7 May 2022 10:00 AM ISTAccording to recently published articles in The Lancet Infectious Diseases journal, the climbing numbers of gonorrhea cases across the globe are an...
Journal Club - Antibiotics in children below 2 years to cause low vaccine response Dr. Nandita Mohan5 May 2022 10:15 AM ISTThe majority of children are given antibiotics in the first 2 years of life when vaccine-induced immunity develops. Previous studies have shown a...
Antibiotics use in children below 2 years tied to reduced vaccine response: Study Medha Baranwal3 May 2022 10:00 AM ISTNew York: Antibiotic use in children aged 6 to 24 months is associated with reduced vaccine-induced antibody levels to several vaccines, states a...
Pfizer vaccines head Kathrin Jansen to retire this year Ruchika Sharma1 May 2022 10:00 AM ISTShe previously led vaccine research at vaccines and health care products maker Wyeth, which was acquired by Pfizer over a decade ago.
Meningococcal B vaccine may have protective role against gonorrhoea: Lancet Dr. Kamal Kant Kohli14 April 2022 10:00 AM ISTResearchers at The University of Adelaide have found that the meningococcal B vaccine could improve protection against gonorrhoea in addition to...
BioNTech COVID vaccine causes deafness: WHO Isra Zaman5 April 2022 2:58 PM ISTAccording to a VigiBase report from WHO, instances of auditory loss also referred to as tinnitus was observed in people who were given Covid-19...
Immunocompromised COVID-19 patient successfully treated with vaccine: Case report Medha Baranwal23 March 2022 7:21 PM ISTUK: A recent case study, published in the Journal of Clinical Immunology, describes the case of a man in the UK who tested positive for coronavirus...
COVID vaccine Corbevax to cost Rs 145 for govt, Rs 990 in private market Revu suresh19 March 2022 2:40 PM ISTNew Delhi: The COVID-19 vaccine administered for children aged between 12 and 14 years, Corbevax, is being sold to the government at Rs 145 per dose,...
PFIZER Clostridium difficile Vaccine did not meet primary endpoints: PHASE 3 CLOVER Trial MD Bureau6 March 2022 1:29 PM ISTNew York: Pfizer Inc. announced results from the CLOVER trial (CLOstridium difficile Vaccine Efficacy TRial), a pivotal Phase 3 study evaluating its...
Newer Vaccine may prevent Triple Negative Breast Cancer for the first time Dr Nisanth Puliyath12 Feb 2022 9:00 AM ISTThe Cleveland Clinic has begun clinical testing of a novel vaccine designed ultimately to prevent triple-negative breast cancer (TNBC) by priming...
COVID :Indian scientists designed a vaccine for all variants of corona virus Medical Dialogues Bureau7 Feb 2022 11:20 AM ISTNew Delhi: Indian scientists claim to have designed a universal vaccine that can be effective against all variants of the coronavirus, which triggered...
SC pulls up vaccine doubter, says court's shoulders broad to take criticism MD Bureau26 Jan 2022 10:00 AM ISTConcluding the hearing in the matter, the top court left it open for the Central government to consider suggestions for making software adjustment to...
